MEDLEY (FRA:3YV) Long-Term Debt: €67.4 Mil (As of Dec. 2025)


FRA:3YV MEDLEY Inc FRA:3YV
76 GF Score
Price €10.90
GF Value €36.58
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is MEDLEY Long-Term Debt?

MEDLEY FRA:3YV +0.93% 76 Long-Term Debt is €67.4 Mil as of Dec. 2025. GuruFocus rates FRA:3YV with a GF Score™ of 76/100 and a GF Value™ of €36.58 (Significantly Undervalued). The stock has 3 warning signs investors should review.

MEDLEY's Long-Term Debt for the quarter that ended in Dec. 2025 was €67.4 Mil.

MEDLEY's quarterly Long-Term Debt declined from Jun. 2025 (€85.3 Mil) to Sep. 2025 (€76.3 Mil) and declined from Sep. 2025 (€76.3 Mil) to Dec. 2025 (€67.4 Mil).

MEDLEY's annual Long-Term Debt increased from Dec. 2023 (€5.9 Mil) to Dec. 2024 (€71.8 Mil) but then declined from Dec. 2024 (€71.8 Mil) to Dec. 2025 (€67.4 Mil).

MEDLEY  (FRA:3YV) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

MEDLEY Long-Term Debt Related Terms

MEDLEY Long-Term Debt Historical Data

* Premium members only.

The historical data trend for MEDLEY's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDLEY Long-Term Debt Chart

MEDLEY Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 16.89 11.22 5.91 71.80 67.37

MEDLEY Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.80 94.67 85.33 76.30 67.37
FRA:3YV
76GF Score
MEDLEY Inc FRA:3YV
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €67.4 Mil mean?
MEDLEY (FRA:3YV) has a Long-Term Debt of €67.4 Mil as of Dec. 2025.
Is MEDLEY's Long-Term Debt too high?
MEDLEY's current Long-Term Debt is €67.4 Mil. Overall, MEDLEY has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDLEY's Long-Term Debt compare to VEEV and BTSG?
MEDLEY's Long-Term Debt of €67.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. MEDLEY's current Long-Term Debt is €67.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDLEY stock overvalued right now?
Based on GuruFocus' analysis, MEDLEY (FRA:3YV) is currently considered Significantly Undervalued. The stock's GF Value™ is €36.58, compared to a current price of €10.90 — trading 70.2% below its estimated fair value. The current Long-Term Debt is €67.4 Mil. MEDLEY's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For MEDLEY (FRA:3YV), the current Long-Term Debt is €67.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDLEY (FRA:3YV) Overvalued in 2026?

Based on GuruFocus' analysis, MEDLEY stock appears to be undervalued. The current stock price of €10.90 is trading 70.2% below its estimated GF Value™ of €36.58. GuruFocus considers MEDLEY to be Significantly Undervalued.

Key valuation signals for FRA:3YV:

  • Long-Term Debt: €67.4 Mil
  • GF Value™: €36.58 vs. price of €10.90 (70.2% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the FRA:3YV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MEDLEY Business Description

Other Exchanges MDLYF:USA4480:Japan
Address 3-2-1 Roppongi, Minato-ku, 22nd Floor Sumitomo Fudosan Roppongi Grand Tower, Tokyo, JPN, 106-6222
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.
76GF Score

Get the complete analysis for FRA:3YV

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.90
Price
€36.58
GF Value